![]() Indian Express |
![]() Express India |
![]() Screen |
![]() Loksatta |
![]() Express Cricket |
![]() Kashmir Live |
![]() Biz Publications |





: It is never easy to part with a prized possession. Not unless, you know that tomorrow it will turn into a white elephant. Jayesh P Choksi, chairman and managing director of Gufic Biosciences was quick to make hay while the sun shone. In March 1999, he mowed down the size of his company from roughly Rs 100 crore to a mere Rs 20 crore by selling of its formulations divisions to pharma major Ranbaxy. Criticised initially for such a drastic decision, on hindsight, Mr Choksi is certain that his decision was a wise one.
![]() |
| Jayesh P Choksi, Chairman and MD, Gufic Biosciences |
Mr Choksi opted to get out of its formulations and concentrate on R&D in the herbal segment, despite the fact that many of its brands like Mox in the amoxycilin segment were brand leaders. “Initially there were many who laughed at my decision and it is those very...
More from India Inc
| Single Page Format | 1 - 2 - 3 - 4 - Next |
![]() |
![]() |
![]() |


© 2009: The Indian Express Limited. All rights reserved throughout the world